Ingredients
USP Issues New Quality Standards for Heparin
October 08, 2009
The US Food and Drug Administration issued an alert to healthcare professionals of a change in heparin manufacturing that is expected to decrease the drug's potency.
Nobel Prize Awarded for Research in the Role of a Chromosome Protector in Cell Division
October 08, 2009
The 2009 Nobel Prize in Physiology or Medicine was awarded to three US researchers for the discovery of how chromosomes are protected from degradation by telomeres and the enzyme telomerase during cell division.
Companies Update Pandemic (H1N1) Flu Vaccine Projects
October 08, 2009
GlaxoSmithKline (London), Novartis (Basel, Switzerland), sanofi Aventis (Paris), and Baxter International (Deerfield, IL) recently provided updates as to the development, manufacture, or shipment of pandemic (H1NI) vaccines.
Week of Oct. 5, 2009: Merck and CSL Sign Flu Vaccine Pact; Cardinal Health Names VP; More...
October 08, 2009
Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech; Sigma-Aldrich appoints VP and board member; more...
Looking Ahead: The Pharmaceutical-Science Industry
October 02, 2009
AAPS President offers hope and solutions for the industry's challenging future.
PhRMA's Stake in Reform
October 02, 2009
The nation's healtcare system needs an overhaul, but it has to be done right.
Delivering the Results in Drug-Based Nanotechnology
October 02, 2009
New nanotechnology-based delivery systems offer promise in drug delivery, particularly for anticancer therapeutics.
Defining the ideal properties of a moisture protective, instant release film coating
October 01, 2009
Applying a moisture protective barrier to tablet cores can help prevent degradation caused by ambient moisture.
Seattle Genetics Introduces Sugar-Engineered Antibody Technology
October 01, 2009
The biopharmaceutical company Seattle Genetics (Bothell, WA) introduced a sugar-engineered antibody (SEA) technology that is designed to increase the potency of monoclonal antibodies through enhanced effector function.
Week of Sept. 28, 2009: J&J and Crucell Enter Collaboration; Pfizer Elects Two Directors; More...
October 01, 2009
Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam Molecular Therapeutics appoints CEO; more...